In contemporary oncology research, phase 3 clinical trials hold a pivotal role in the development and approval of new cancer therapies. These trials are traditionally...
Emerging research from the University of California, Davis, sheds new light on the potentially harmful effects of nanoplastics—foreign microscopic particles increasingly pervasive in food and...
A groundbreaking study involving nearly 200,000 participants observed over multiple decades has shed new light on the ongoing debate surrounding diet quality and cardiovascular health....
In the evolving landscape of neuro-oncology, brain metastases pose a formidable challenge, often impacting patient survival and quality of life. Recent advances in microsurgical techniques...
In a groundbreaking development at the intersection of biology, electronics, and robotics, researchers have pioneered a novel method to control the locomotion of insects by...
Recent investigations into cardiometabolic health have shed new light on the impact of linoleic acid, a predominant omega-6 fatty acid found chiefly in seed oils...
In a groundbreaking leap forward for brain cancer treatment, researchers from the University of Pennsylvania have unveiled promising results from a novel dual-target CAR T...
In a groundbreaking advancement that promises to redefine wearable health monitoring technologies, researchers have unveiled a novel pulse oximetry sensor distinguished by its innovative all-organic,...
In a groundbreaking advancement for colorectal cancer treatment, the Alliance for Clinical Trials in Oncology revealed pivotal results from the phase III ATOMIC (A021502) trial...
Recent advances in neuroimaging and neuropathology have begun to unravel the intricate complexities underlying neurodegenerative diseases, notably dementia with Lewy bodies (DLB). A groundbreaking study...
The intricate interplay between viral glycoproteins and host cellular mechanisms has long been recognized as a pivotal determinant of viral infectivity and transmission dynamics. In...
In a groundbreaking advancement presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, researchers from Dana-Farber Cancer Institute have unveiled compelling evidence...
In a landmark development poised to redefine the landscape of flexible electronics, researchers led by Zhang, Jiang, and Hong have unveiled an ultra-flexible graphene-metal nanomembrane...
The clinical investigation, known as the SERENA-6 trial, was published on June 1, 2025, in the prestigious New England Journal of Medicine and presented simultaneously...
A groundbreaking new analysis from Dana-Farber Cancer Institute highlights a significant link between diet, physical activity, and survival outcomes in patients treated for stage III...
